Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery
This study is currently recruiting participants.
Study NCT00645138   Information provided by Weill Medical College of Cornell University
First Received: March 19, 2008   Last Updated: April 30, 2009   History of Changes

March 19, 2008
April 30, 2009
April 2008
February 2010   (final data collection date for primary outcome measure)
  • Time in minutes until the patient is declared ready for discharge from the Post Anesthesia Care Unit (PACU) [ Time Frame: Until PACU discharge ] [ Designated as safety issue: No ]
  • Visual Analog Scale (VAS) pain scores at 30, 60, 90, and 120 minutes after PACU admission. A VAS score will also be assessed on the first postoperative day. [ Time Frame: Until PACU discharge and for 24 hours ] [ Designated as safety issue: No ]
  • Time in minutes until the patient is declared ready for discharge from the Post Anethesia Care Unit (PACU) [ Time Frame: Until PACU discharge ] [ Designated as safety issue: No ]
  • Visual Analog Scale (VAS) pain scores at 30, 60, 90, and 120 minutes after PACU admission. A VAS score will also be assessed on the first postoperative day. [ Time Frame: Until PACU discharge and for 24 hours ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00645138 on ClinicalTrials.gov Archive Site
  • The need for postoperative opioids in the PACU and during the first postoperative day will be assessed. [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Episodes of nausea or vomiting in the PACU and during the first postoperative day will be assessed. [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Total time spent in the operating room [ Time Frame: Perioperative ] [ Designated as safety issue: No ]
  • Overall patient satisfaction [ Time Frame: After hospital discharge ] [ Designated as safety issue: No ]
Same as current
 
Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery
A Comparison of Ultrasound-Assisted Paravertebral Block and General Anesthesia for Outpatient Breast Cancer Surgery, a Prospective Randomized Trial

The purpose of this project is to determine if there is a difference between paravertebral block and general anesthesia in terms of time to discharge from the Post-Anesthesia Care Unit and pain level in patients undergoing outpatient breast cancer surgery.

The optimal anesthetic technique for breast cancer surgery allows for good postoperative pain relief and rapid discharge. Breast cancer surgery with potential axillary dissection is often performed under general anesthesia due to the potential for poor analgesia with local anesthetic infiltration at the surgical site alone. General anesthesia can be associated with increased post-operative pain, nausea, and delayed discharge when compared to regional anesthesia for breast and other types of procedures (1,2).

The paravertebral block is a technique that has been used perioperatively for breast (3,4), thoracic (5), abdominal (6), and hernia surgeries (7). It has also been used for pain control after rib fractures and penetrating trauma (8,9). The paravertebral block is performed by injecting local anesthetic above or below the transverse processes of the vertebral bodies where the spinal nerve roots emerge from the intervertebral foramina. The most common technique is to insert a needle 2.5 centimeters lateral to the spinous process at each level and "walk off" the transverse process. Injections at one or multiple levels block the somatic and sympathetic innervation to these dermatomes (10).

Rare complications of thoracic paravertebral blocks include epidural spread, intrathecal injection, and Horner's Syndrome (1,11,12). One of the most feared complications of the traditional technique is pleural puncture, which has an incidence of 0.64% to 6.7% in the published literature (3,11,13).

Ultrasound guidance in regional anesthesia is gaining widespread popularity. This technology provides visualization of key anatomic structures and has been shown to decrease block placement and onset times (14,15) and improve patient comfort (15). Ultrasound-guided blocks are associated with success rates of greater than 90% (15,16). In the thoracic region, ultrasound can be used to identify the vertebral transverse processes, as well as the ribs and the pleura of the lungs (17). In this way, pleural puncture can be avoided during paravertebral block placement.

To date there have been no published prospective, randomized trials comparing the multiple injection thoracic paravertebral technique using ultrasound guidance to general anesthesia in breast cancer surgery patients.

Our hypothesis is that paravertebral block anesthesia will result in shorter Post Anesthesia Care Unit (PACU) stays and decreased Visual Analog Scale (VAS) scores when compared to general anesthesia in patients undergoing breast cancer surgery. Secondary endpoints will include the need for postoperative opioids and the presence of nausea and/or vomiting.

Phase III
Interventional
Treatment, Randomized, Single Blind (Outcomes Assessor), Parallel Assignment
Breast Cancer
  • Procedure: Paravertebral Block
  • Procedure: General Anesthesia
  • Active Comparator: Patients receiving Paravertebral Block.
  • Active Comparator: Patients receiving General Anesthesia.

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
70
February 2010
February 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women 18 years of age or older with suspected breast carcinoma scheduled for unilateral lumpectomy or mass excision with sentinel node biopsy and possible axillary dissection.

Exclusion Criteria:

  • A diagnosis of chronic pain, regular use of opioid medications, infection at the injection site, allergy to amide local anesthetics, bleeding disorder, contraindication to LMA, and patient refusal.
Female
18 Years and older
No
Contact: Kathryn Koval, BA 212-746-2952 kak2006@med.cornell.edu
United States
 
NCT00645138
Tiffany Tedore MD, New York Presbyterian Hospital Weill Cornell Medical Center
0801009584
Weill Medical College of Cornell University
 
Principal Investigator: Tiffany Tedore, M.D. New York Presbyterian Hospital Weill Cornell Medical Center
Weill Medical College of Cornell University
April 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP